Niacin activates the G protein estrogen receptor (GPER)-mediated signalling

Maria Francesca Santolla, Ernestina Marianna De Francesco, Rosamaria Lappano, Camillo Rosano, Sergio Abonante, Marcello Maggiolini

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Nicotinic acid, also known as niacin, is the water soluble vitamin B3 used for decades for the treatment of dyslipidemic diseases. Its action is mainly mediated by the G protein-coupled receptor (GPR) 109A; however, certain regulatory effects on lipid levels occur in a GPR109A-independent manner. The amide form of nicotinic acid, named nicotinamide, acts as a vitamin although neither activates the GPR109A nor exhibits the pharmacological properties of nicotinic acid. In the present study, we demonstrate for the first time that nicotinic acid and nicotinamide bind to and activate the GPER-mediated signalling in breast cancer cells and cancer-associated fibroblasts (CAFs). In particular, we show that both molecules are able to promote the up-regulation of well established GPER target genes through the EGFR/ERK transduction pathway. As a biological counterpart, nicotinic acid and nicotinamide induce proliferative and migratory effects in breast cancer cells and CAFs in a GPER-dependent fashion. Moreover, nicotinic acid prevents the up-regulation of ICAM-1 triggered by the pro-inflammatory cytokine TNF-α and stimulates the formation of endothelial tubes through GPER in HUVECs. Together, our findings concerning the agonist activity for GPER displayed by both nicotinic acid and nicotinamide broaden the mechanisms involved in the biological action of these molecules and further support the potential of a ligand to induce different responses mediated in a promiscuous manner by distinct GPCRs.

Original languageEnglish
Pages (from-to)1466-1475
Number of pages10
JournalCellular Signalling
Volume26
Issue number7
DOIs
Publication statusPublished - 2014

Fingerprint

Niacin
GTP-Binding Proteins
Estrogen Receptors
Niacinamide
Up-Regulation
Breast Neoplasms
erbB-1 Genes
MAP Kinase Signaling System
Intercellular Adhesion Molecule-1
G-Protein-Coupled Receptors
Amides
Vitamins
Pharmacology
Cytokines
Ligands
Lipids
Water

Keywords

  • Breast cancer cells
  • Cancer-associated fibroblasts
  • GPER
  • Nicotinamide
  • Nicotinic acid

ASJC Scopus subject areas

  • Cell Biology
  • Medicine(all)

Cite this

Santolla, M. F., De Francesco, E. M., Lappano, R., Rosano, C., Abonante, S., & Maggiolini, M. (2014). Niacin activates the G protein estrogen receptor (GPER)-mediated signalling. Cellular Signalling, 26(7), 1466-1475. https://doi.org/10.1016/j.cellsig.2014.03.011

Niacin activates the G protein estrogen receptor (GPER)-mediated signalling. / Santolla, Maria Francesca; De Francesco, Ernestina Marianna; Lappano, Rosamaria; Rosano, Camillo; Abonante, Sergio; Maggiolini, Marcello.

In: Cellular Signalling, Vol. 26, No. 7, 2014, p. 1466-1475.

Research output: Contribution to journalArticle

Santolla, MF, De Francesco, EM, Lappano, R, Rosano, C, Abonante, S & Maggiolini, M 2014, 'Niacin activates the G protein estrogen receptor (GPER)-mediated signalling', Cellular Signalling, vol. 26, no. 7, pp. 1466-1475. https://doi.org/10.1016/j.cellsig.2014.03.011
Santolla, Maria Francesca ; De Francesco, Ernestina Marianna ; Lappano, Rosamaria ; Rosano, Camillo ; Abonante, Sergio ; Maggiolini, Marcello. / Niacin activates the G protein estrogen receptor (GPER)-mediated signalling. In: Cellular Signalling. 2014 ; Vol. 26, No. 7. pp. 1466-1475.
@article{e3e93395d6344caeaf3dd1b37099a00c,
title = "Niacin activates the G protein estrogen receptor (GPER)-mediated signalling",
abstract = "Nicotinic acid, also known as niacin, is the water soluble vitamin B3 used for decades for the treatment of dyslipidemic diseases. Its action is mainly mediated by the G protein-coupled receptor (GPR) 109A; however, certain regulatory effects on lipid levels occur in a GPR109A-independent manner. The amide form of nicotinic acid, named nicotinamide, acts as a vitamin although neither activates the GPR109A nor exhibits the pharmacological properties of nicotinic acid. In the present study, we demonstrate for the first time that nicotinic acid and nicotinamide bind to and activate the GPER-mediated signalling in breast cancer cells and cancer-associated fibroblasts (CAFs). In particular, we show that both molecules are able to promote the up-regulation of well established GPER target genes through the EGFR/ERK transduction pathway. As a biological counterpart, nicotinic acid and nicotinamide induce proliferative and migratory effects in breast cancer cells and CAFs in a GPER-dependent fashion. Moreover, nicotinic acid prevents the up-regulation of ICAM-1 triggered by the pro-inflammatory cytokine TNF-α and stimulates the formation of endothelial tubes through GPER in HUVECs. Together, our findings concerning the agonist activity for GPER displayed by both nicotinic acid and nicotinamide broaden the mechanisms involved in the biological action of these molecules and further support the potential of a ligand to induce different responses mediated in a promiscuous manner by distinct GPCRs.",
keywords = "Breast cancer cells, Cancer-associated fibroblasts, GPER, Nicotinamide, Nicotinic acid",
author = "Santolla, {Maria Francesca} and {De Francesco}, {Ernestina Marianna} and Rosamaria Lappano and Camillo Rosano and Sergio Abonante and Marcello Maggiolini",
year = "2014",
doi = "10.1016/j.cellsig.2014.03.011",
language = "English",
volume = "26",
pages = "1466--1475",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Niacin activates the G protein estrogen receptor (GPER)-mediated signalling

AU - Santolla, Maria Francesca

AU - De Francesco, Ernestina Marianna

AU - Lappano, Rosamaria

AU - Rosano, Camillo

AU - Abonante, Sergio

AU - Maggiolini, Marcello

PY - 2014

Y1 - 2014

N2 - Nicotinic acid, also known as niacin, is the water soluble vitamin B3 used for decades for the treatment of dyslipidemic diseases. Its action is mainly mediated by the G protein-coupled receptor (GPR) 109A; however, certain regulatory effects on lipid levels occur in a GPR109A-independent manner. The amide form of nicotinic acid, named nicotinamide, acts as a vitamin although neither activates the GPR109A nor exhibits the pharmacological properties of nicotinic acid. In the present study, we demonstrate for the first time that nicotinic acid and nicotinamide bind to and activate the GPER-mediated signalling in breast cancer cells and cancer-associated fibroblasts (CAFs). In particular, we show that both molecules are able to promote the up-regulation of well established GPER target genes through the EGFR/ERK transduction pathway. As a biological counterpart, nicotinic acid and nicotinamide induce proliferative and migratory effects in breast cancer cells and CAFs in a GPER-dependent fashion. Moreover, nicotinic acid prevents the up-regulation of ICAM-1 triggered by the pro-inflammatory cytokine TNF-α and stimulates the formation of endothelial tubes through GPER in HUVECs. Together, our findings concerning the agonist activity for GPER displayed by both nicotinic acid and nicotinamide broaden the mechanisms involved in the biological action of these molecules and further support the potential of a ligand to induce different responses mediated in a promiscuous manner by distinct GPCRs.

AB - Nicotinic acid, also known as niacin, is the water soluble vitamin B3 used for decades for the treatment of dyslipidemic diseases. Its action is mainly mediated by the G protein-coupled receptor (GPR) 109A; however, certain regulatory effects on lipid levels occur in a GPR109A-independent manner. The amide form of nicotinic acid, named nicotinamide, acts as a vitamin although neither activates the GPR109A nor exhibits the pharmacological properties of nicotinic acid. In the present study, we demonstrate for the first time that nicotinic acid and nicotinamide bind to and activate the GPER-mediated signalling in breast cancer cells and cancer-associated fibroblasts (CAFs). In particular, we show that both molecules are able to promote the up-regulation of well established GPER target genes through the EGFR/ERK transduction pathway. As a biological counterpart, nicotinic acid and nicotinamide induce proliferative and migratory effects in breast cancer cells and CAFs in a GPER-dependent fashion. Moreover, nicotinic acid prevents the up-regulation of ICAM-1 triggered by the pro-inflammatory cytokine TNF-α and stimulates the formation of endothelial tubes through GPER in HUVECs. Together, our findings concerning the agonist activity for GPER displayed by both nicotinic acid and nicotinamide broaden the mechanisms involved in the biological action of these molecules and further support the potential of a ligand to induce different responses mediated in a promiscuous manner by distinct GPCRs.

KW - Breast cancer cells

KW - Cancer-associated fibroblasts

KW - GPER

KW - Nicotinamide

KW - Nicotinic acid

UR - http://www.scopus.com/inward/record.url?scp=84897510110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897510110&partnerID=8YFLogxK

U2 - 10.1016/j.cellsig.2014.03.011

DO - 10.1016/j.cellsig.2014.03.011

M3 - Article

C2 - 24662263

AN - SCOPUS:84897510110

VL - 26

SP - 1466

EP - 1475

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 7

ER -